List of works - Elena Provenzano

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer

scientific article

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

scientific article published on 2 July 2015

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

scientific article published in Nature Communications

DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation

scientific article published on 13 September 2021

Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

scientific article published on 6 June 2016

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

scientific article

Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer

scientific article

Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study

scientific article

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

scientific article

Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

scientific article

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response

scientific article published on 31 March 2021

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

scientific article

Multi-omic machine learning predictor of breast cancer therapy response

scientific article published on 07 December 2021

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer

scientific article

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

scientific article published on 4 December 2014

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.

scientific article published on 30 May 2019

Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling

scientific article

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

scientific article

Regulation of p53 tetramerization and nuclear export by ARC

scientific article published on 26 December 2007

Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.

scientific article published on 30 March 2018

Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

scientific article published on 01 August 2020

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

scientific article

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

scientific article published on 5 February 2017

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups ⬇️

scientific article (publication date: 18 April 2012)

The important role of the histopathologist in clinical trials: challenges and approaches to tackle them

scientific article published on 07 March 2020

The shaping and functional consequences of the microRNA landscape in breast cancer

scientific article published on 5 May 2013

The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

scientific article

Updated UK Recommendations for HER2 assessment in breast cancer

scientific article

List of works by Elena Provenzano

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation

Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer

Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

Multi-omic machine learning predictor of breast cancer therapy response

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.

Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Regulation of p53 tetramerization and nuclear export by ARC

Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.

Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups ⬇️

The important role of the histopathologist in clinical trials: challenges and approaches to tackle them

The shaping and functional consequences of the microRNA landscape in breast cancer

The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

Updated UK Recommendations for HER2 assessment in breast cancer